RecruitingNCT02000687

Long Term Surveillance of Islet Transplant Recipients Following Complete Graft Loss


Sponsor

Rodolfo Alejandro

Enrollment

60 participants

Start Date

Dec 1, 2008

Study Type

OBSERVATIONAL

Conditions

Summary

This is a single-center, prospective, open label study in islet transplant recipients following islet graft loss.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study is monitoring the long-term health of people who received an islet cell transplant (a procedure that places insulin-producing cells into people with type 1 diabetes) using a specific immune-suppressing drug protocol, to see how well they do over time. **You may be eligible if...** - You have type 1 diabetes and previously received an islet transplant at a participating institution - You received your transplant under a specific research protocol being tracked by this study - You are willing to be followed with regular check-ups and lab tests over many years **You may NOT be eligible if...** - Your islet transplant is no longer functional - You did not receive your transplant under the specific research protocol this study is following - You are unable or unwilling to comply with ongoing long-term monitoring requirements Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Diabetes Research Institute

Miami, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02000687


Related Trials